Apr 23 |
Silo Pharma Announces Positive Results for Intranasal PTSD Treatment
|
Apr 10 |
Silo Pharma set to acquire licensing for Alzheimer’s disease therapeutic
|
Apr 10 |
Silo Pharma set to Acquire Exclusive Licensing for Promising Alzheimer’s Disease Therapeutic
|
Apr 9 |
Citizens And 2 Other Stocks Under $3 Insiders Are Buying
|
Apr 2 |
Silo Pharma And 3 Other Stocks Under $5 Insiders Are Buying
|
Mar 30 |
Psychedelics Headlines: A Form Of Life, Treating Chronic Pain, Microdosing And More
|
Mar 20 |
Silo Pharma Exercises Option for Exclusive License Agreement for First-in-Class PTSD and Stress-Induced Anxiety Therapeutic
|
Mar 18 |
Silo Pharma Files Patent for Groundbreaking Ketamine Implant Therapeutic to Target Fibromyalgia and Chronic Pain
|
Feb 28 |
Silo Pharma Completes Successful Dose-Ranging Study of SPC-15 Intranasal Therapeutic for PTSD
|
Feb 14 |
Silo Pharma’s SP-26 Ketamine Implant Demonstrates Successful Drug Delivery
|